iCardio.ai
PrivateLast Round
Grant
Mar 5, 2025
Est. Valuation
$2M
Total Funding Raised
$2.27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
iCardio.ai operates in Healthcare & Life Sciences and is based in West Hollywood, California. Its latest recorded funding round was a Grant round in March 2025.
iCardio.ai is a healthtech company that develops machine learning and deep learning algorithms for the analysis of ultrasound applications, with a specific focus on echocardiography.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Revenue Share, Subscription SaaS, Usage-Based SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iCardio.ai Comparables
Compare iCardio.ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Us2.ai | 87% | |
| Ligence | 86% | |
| InVision Medical Technology | 83% |
For institutional investors. Book with your work email.
iCardio.ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 5, 2025 | ||||
| Accelerator | Mar 29, 2023 | ||||
| Accelerator | Oct 6, 2022 | ||||
| Strategic | Jun 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
iCardio.ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| HTA | Accelerator |
| The Roddenberry Foundation | Grant |
| HeartX Accelerator | Accelerator |
| BSD Enterprises | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 138% MoM, reaching 3.8K.
- Sep 6, 2025
Grew 22% QoQ, from 18 to 22 employees.
For institutional investors. Book with your work email.
iCardio.ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iCardio.ai's valuation, stock price, and market status.
Is iCardio.ai a public or private company?
iCardio.ai is a private company.
What is the current stock price of iCardio.ai?
iCardio.ai is a private company, so its shares have no public market price. Caplight tracks iCardio.ai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iCardio.ai worth (valuation)?
iCardio.ai's valuation is estimated at $2.0M based on funding round data.
Can I buy iCardio.ai stock?
iCardio.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iCardio.ai's last funding round?
iCardio.ai's most recent funding round was Grant on March 5, 2025.
Who are the main investors in iCardio.ai?
Key investors in iCardio.ai include BSD Enterprises.
Will iCardio.ai IPO soon?
No public IPO plans have been announced for iCardio.ai.
How can I track iCardio.ai secondary market activity?
Caplight tracks bids, offers, and trades in iCardio.ai's shares on secondary markets.